Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending April 16, 2007. The report details a specific corporate action regarding a share repurchase executed in accordance with shareholder authority granted at the Annual General Meeting on May 17, 2006.
Key Financial Metrics
The filing does not provide data on revenue, profit, cash flow, margins, debt, or liquidity. The only financial metric disclosed is the share repurchase price of 1,474.7307 pence per share.
Material Changes
- Share Repurchase: The Company purchased 500,000 Ordinary shares of 25 pence each on April 16, 2007.
- Treasury Holdings: Following the transaction, the Company holds 286,142,678 shares in Treasury.
- Shares in Issue: The total number of shares in issue (excluding Treasury shares) is 5,725,289,167.
Guidance, Outlook, and Risks
The filing contains no management commentary, future guidance, risk factors, or contingencies. It explicitly states that the announcement does not constitute an offer or solicitation to purchase securities.
Investor Verification Checklist
- Verify the total number of shares in issue (5,725,289,167) for calculating disclosure thresholds under Financial Services Authority rules.
- Confirm the updated Treasury share count (286,142,678) for accurate outstanding share calculations.
- Note that this filing is a routine disclosure of a share buyback and does not contain operational or financial performance data.